Dr Reddys launches generic version of Sensipar tablets in US
Dr. Reddy's Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30.
Hyderabad & Princeton: Drugmaker, Dr. Reddy's Laboratories Ltd., has recently announced the launch of Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets, approved by the U.S. Food and Drug Administration (USFDA).
Cinacalcet tablet is a positive modulator of the calcium sensing receptor indicated for:
• Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis.
• Hypercalcemia in adult patients with Parathyroid Carcinoma (PC).
• Severe hypercalcemia in adult patients with primary HPT who are unable to undergo parathyroidectomy.
Dr. Reddy's Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30.
Sensipar is a trademark of Amgen Inc.
Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology.
